At Origimm (‘Origins of Immunity’), we are discovering the origins of the protective immune response to develop breakthrough therapies targeting the cause of a disease rather than its symptoms.

Origimm’s inception began with Sanja Selak’s desire to develop more reliable research methods to deliver better medicinal products. Skin diseases especially drew her attention due to the additional burden of suffering caused by the external disease manifestation which frequently leads to deep emotional struggles and wounds. The very personal stories from the patients who struggle with this skin disease are the driving force behind our efforts and our motivation.

Over the years, Sanja Selak gradually recruited team members sharing her vision and values. From 2012 to 2014, the company operated as a sole proprietorship. In 2014 the company was converted to a limited liability company (GmbH).

sanja selak: origimm biotechnology, vienna-